Shah Pratik

CIK 00015807875 companiesCARLSBAD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001580787

Recent Transactions

36 trades

Award
Design Therapeutics, Inc.$DSGN
Stock option (right to buy)
2026-01-02+750,000→ 750,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock option (right to buy)
2025-12-09+525,000→ 525,000 total
Gift
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-11-12−100,000→ 4,474,554 total
Gift
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-11-12−250,000→ 4,574,554 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2025-06-25+30,000→ 30,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock option (right to buy)
2025-01-02+600,000→ 600,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2024-06-20+40,000→ 40,000 total
Gift
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-13−200,000→ 1,132,900 total
Gift
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-13−1,132,900→ 0 total
Gift
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-07−1,332,950→ 4,824,554 total
Gift
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-04+1,332,900→ 1,332,900 total
Other
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-04−2,665,800→ 7,490,404 total
Other
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-04−2,665,800→ 7,490,404 total
Gift
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-04−1,332,900→ 6,157,504 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2023-09-01+1,050,000→ 1,050,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2023-09-01+525,000→ 525,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2023-09-01+525,000→ 525,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2023-06-27+40,000→ 40,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2023-02-01+415,000→ 415,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Employee Stock Option (right to buy)
2022-11-08+354,570→ 354,570 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2022-11-08+10,156,204→ 10,156,204 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2022-02-01+475,000→ 475,000 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30$20.00/sh+25,000→ 25,000 total
Conversion
Design Therapeutics, Inc.$DSGN
Series A Preferred Stock
2021-03-30−171,025→ 0 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+104,923→ 129,923 total
Disposition from Tender
Synthorx, Inc.
Common Stock
2020-01-23$68.00/sh−62,412→ 0 total
Disposition to Issuer
Synthorx, Inc.
Stock Option (right to buy)
2020-01-23$55.60/sh−10,223→ 0 total
Award
Synthorx, Inc.
Stock Option (right to buy)
2019-06-07+10,223→ 10,223 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2015-05-05−215,153→ 0 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Restricted Stock Units
2015-05-05−100,000→ 0 total
Disposition from Tender
Auspex Pharmaceuticals, Inc.
Common Stock
2015-05-05−903,018→ 0 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2015-05-05−200,000→ 0 total
Award
Auspex Pharmaceuticals, Inc.
Stock Option (right to buy)
2015-02-02+200,000→ 200,000 total
Award
Auspex Pharmaceuticals, Inc.
Restricted Stock Units
2015-02-02+100,000→ 100,000 total
Purchase
Auspex Pharmaceuticals, Inc.
Common Stock
2014-02-10$12.00/sh+8,333→ 903,018 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2013-08-30+20,000→ 20,000 total

Shah Pratik

Recent Transactions

Companies

Recent Filings

Address